Virbac S.A (VIRP) | Financial Analysis & Statements
Virbac S.A. Large-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Income Metrics
Balance Sheet Metrics
Total Assets
1.8B
Total Liabilities
750.3M
Shareholders Equity
1.1B
Debt to Equity
0.70
Cash Flow Metrics
Revenue & Profitability Trend
Annual Income Flow
2024
Virbac S.A Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 1.4B | 1.2B | 1.2B | 1.1B | 934.2M |
| Cost of Goods Sold | 459.8M | 437.3M | 426.2M | 363.1M | 319.9M |
| Gross Profit | 937.6M | 809.6M | 790.0M | 700.9M | 614.3M |
| Gross Margin % | 67.1% | 64.9% | 65.0% | 65.9% | 65.8% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | - | - | - | 203.5M | 159.6M |
| Other Operating Expenses | 280.3M | 247.6M | 250.8M | 208.8M | 14.3M |
| Total Operating Expenses | 280.3M | 247.6M | 250.8M | 412.2M | 174.0M |
| Operating Income | 228.3M | 185.7M | 183.5M | 166.8M | 122.9M |
| Operating Margin % | 16.3% | 14.9% | 15.1% | 15.7% | 13.2% |
| Non-Operating Items | |||||
| Interest Income | 6.4M | 8.7M | 4.8M | 2.4M | 2.0M |
| Interest Expense | 11.1M | 8.9M | 3.7M | 6.0M | 10.7M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 207.8M | 174.2M | 176.4M | 159.1M | 173.3M |
| Income Tax | 62.5M | 53.5M | 55.7M | 43.6M | 33.3M |
| Effective Tax Rate % | 30.1% | 30.7% | 31.6% | 27.4% | 19.2% |
| Net Income | 145.8M | 121.1M | 121.3M | 115.7M | 140.3M |
| Net Margin % | 10.4% | 9.7% | 10.0% | 10.9% | 15.0% |
| Key Metrics | |||||
| EBITDA | 289.8M | 226.7M | 236.6M | 217.0M | 179.4M |
| EPS (Basic) | €17.35 | €14.40 | €14.43 | €13.40 | €16.12 |
| EPS (Diluted) | €17.34 | €14.38 | €14.42 | €13.38 | €16.12 |
| Basic Shares Outstanding | 8372978 | 8421787 | 8448180 | 8442111 | 8436696 |
| Diluted Shares Outstanding | 8372978 | 8421787 | 8448180 | 8442111 | 8436696 |
Income Statement Trend
Virbac S.A Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 149.6M | 175.9M | 177.4M | 172.8M | 181.9M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 196.1M | 168.0M | 146.3M | 107.4M | 101.7M |
| Inventory | 404.2M | 339.7M | 330.9M | 270.3M | 211.0M |
| Other Current Assets | - | - | - | - | -1.0K |
| Total Current Assets | 844.1M | 771.5M | 723.5M | 624.7M | 569.8M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 45.6M | 41.1M | 38.4M | 33.4M | 30.9M |
| Goodwill | 804.5M | 515.9M | 444.6M | 429.8M | 414.8M |
| Intangible Assets | 251.2M | 185.1M | 154.4M | 148.7M | 145.3M |
| Long-term Investments | 1.4M | 43.0K | 89.0K | 137.0K | 1.0K |
| Other Non-Current Assets | 4.0K | 3.0K | -1.0K | 2.0K | -2.0K |
| Total Non-Current Assets | 1.0B | 684.2M | 610.1M | 576.9M | 539.7M |
| Total Assets | 1.8B | 1.5B | 1.3B | 1.2B | 1.1B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 174.6M | 149.6M | 155.8M | 127.6M | 105.3M |
| Short-term Debt | 62.7M | 54.5M | 45.0M | 51.9M | 38.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 464.6M | 399.0M | 390.6M | 370.8M | 311.7M |
| Non-Current Liabilities | |||||
| Long-term Debt | 244.3M | 65.6M | 45.4M | 42.6M | 77.4M |
| Deferred Tax Liabilities | 57.2M | 31.6M | 25.8M | 27.9M | 30.3M |
| Other Non-Current Liabilities | -1.0K | -2.0K | -1.0K | -1.0K | -1.0K |
| Total Non-Current Liabilities | 340.6M | 146.8M | 103.7M | 105.6M | 142.6M |
| Total Liabilities | 805.1M | 545.8M | 494.3M | 476.4M | 454.3M |
| Equity | |||||
| Common Stock | 10.5M | 10.6M | 10.6M | 10.6M | 10.6M |
| Retained Earnings | 145.3M | 121.3M | 121.9M | 113.2M | - |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.0B | 909.9M | 839.3M | 725.2M | 655.2M |
| Key Metrics | |||||
| Total Debt | 307.0M | 120.1M | 90.4M | 94.5M | 115.4M |
| Working Capital | 379.6M | 372.4M | 332.9M | 253.9M | 258.1M |
Balance Sheet Composition
Virbac S.A Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 145.8M | 121.1M | 121.3M | 115.7M | 140.3M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -33.3M | -29.4M | -80.2M | -48.9M | -30.1M |
| Operating Cash Flow | 118.0M | 87.6M | 45.2M | 75.0M | 110.0M |
| Investing Activities | |||||
| Capital Expenditures | -69.2M | -41.0M | -38.7M | -33.7M | -22.5M |
| Acquisitions | -348.4M | -62.4M | 0 | -5.9M | 0 |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -417.7M | -103.4M | -38.7M | -39.6M | -22.5M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | -11.1M | -11.2M | -10.6M | -6.3M | - |
| Debt Issuance | 273.6M | 88.7M | 85.4M | 65.6M | 45.0M |
| Debt Repayment | -89.3M | -50.5M | -96.5M | -78.0M | -373.3M |
| Financing Cash Flow | 155.8M | 27.0M | -20.5M | -73.7M | -328.4M |
| Free Cash Flow | 123.8M | 58.7M | 45.4M | 82.7M | 89.9M |
| Net Change in Cash | -143.8M | 11.2M | -14.1M | -38.3M | -240.8M |
Cash Flow Trend
Virbac S.A Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
21.00
Forward P/E
16.46
Price to Book
2.98
Price to Sales
2.16
PEG Ratio
16.46
Profitability Ratios
Profit Margin
10.30%
Operating Margin
13.41%
Return on Equity
13.88%
Return on Assets
7.63%
Financial Health
Current Ratio
1.53
Debt to Equity
25.75
Beta
0.81
Per Share Data
EPS (TTM)
€18.02
Book Value per Share
€127.13
Revenue per Share
€166.89
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| VIRP | 3.2B | 21.00 | 2.98 | 13.88% | 10.30% | 25.75 |
| Sartorius Stedim | 15.8B | 59.45 | 3.86 | 6.59% | 8.98% | 63.11 |
| Ipsen S.A | 13.4B | 30.83 | 3.12 | 10.44% | 11.29% | 22.38 |
Financial data is updated regularly. All figures are in the company's reporting currency.